30 results for "federal policy"
DOJ and marijuana opponents agree on a briefing schedule in a lawsuit challenging federal cannabis rescheduling, impacti…
Read more →Washington state regulators update cannabis rules to align with federal rescheduling, impacting local compliance and ope…
Read more →Washington state creates a pathway for medical cannabis businesses to document operations, easing access to potential fe…
Read more →Iowa Democratic gubernatorial nominee Rob Sand praises Trump administration marijuana rescheduling efforts, highlighting…
Read more →State officials urge DEA for rescheduling guidance as new polls show cannabis replacing alcohol. Stay updated on federal…
Read more →State marijuana regulators demand answers from the DEA regarding federal cannabis rescheduling, creating uncertainty for…
Read more →DEA launches new federal registration forms for medical marijuana manufacturers, distributors, and testing labs to align…
Read more →DEA confirms no cannabis overdose deaths while federal tax guidance advances. Essential updates for dispensary owners an…
Read more →Explore why major cannabis multistate operators are funding political committees supporting anti-marijuana Senate candid…
Read more →VA data shows rising cannabis diagnoses among veterans, but experts urge a closer look at changing screening protocols a…
Read more →DEA confirms zero reported fatal cannabis overdoses in its 2026 edition of the Drugs of Abuse publication, impacting bra…
Read more →Federal officials prioritize cannabis tax guidance following Schedule III rescheduling plans, signaling major financial …
Read more →DEA judge pauses cannabis rescheduling hearings to review a GAO report highlighting procedural flaws at the DEA and FDA.
Read more →New bipartisan bill requires the VA to study medical cannabis for veterans with PTSD and chronic pain, signaling potenti…
Read more →Georgia approves medical marijuana delivery via USPS and private carriers, but federal participation remains uncertain f…
Read more →Bipartisan congressional caucus releases a report on state and federal cooperation for therapeutic psychedelics integrat…
Read more →A GOP congressman backed by cannabis donations opposes legalization, while PA delays reform and MA faces anti-cannabis a…
Read more →VA psilocybin studies highlight growing medical acceptance of alternative therapeutics, signaling potential parallel tre…
Read more →Federal marijuana rescheduling faces new delays as the DEA reviews procedural flaws, extending tax and regulatory uncert…
Read more →GOP Rep. Mike Lawler claims legalization harms society despite receiving campaign funds from major cannabis operators, h…
Read more →DEA judge pauses cannabis rescheduling hearings, delaying federal reform timelines. Get key updates on policy, state mar…
Read more →DEA judge pauses marijuana rescheduling hearings after a federal report highlights gaps in controlled substance evaluati…
Read more →Local officials across the U.S. advance measures to deprioritize psychedelic enforcement, signaling a municipal shift mi…
Read more →DEA marijuana rescheduling requires state coordination to prevent operational disruptions. Learn what federal guidance m…
Read more →DEA moves to ban psychedelics as FDA explores therapeutic access, creating regulatory friction relevant to alternative m…
Read more →Federal watchdog GAO reports gaps in drug scheduling processes as the DEA continues its ongoing review to reschedule can…
Read more →New congressional bill designates cannabis as a high-risk product, requiring enhanced verification for online advertiser…
Read more →Insurance industry groups endorse new congressional legislation to protect carriers serving state-legal cannabis busines…
Read more →Two-thirds of Missouri cannabis operators skipped DEA registration after federal rescheduling. Read the business impact …
Read more →DEA keeps states in the dark on rescheduling as NC weighs state-run stores, IL advances equity payments, and PA holds le…
Read more →